➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
McKesson
Medtronic
Johnson and Johnson
AstraZeneca

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Carbenicillin disodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for carbenicillin disodium and what is the scope of freedom to operate?

Carbenicillin disodium is the generic ingredient in two branded drugs marketed by Roerig and Glaxosmithkline, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for carbenicillin disodium.

Recent Clinical Trials for carbenicillin disodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all carbenicillin disodium clinical trials

US Patents and Regulatory Information for carbenicillin disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-006 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-002 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Roerig GEOPEN carbenicillin disodium INJECTABLE;INJECTION 050306-004 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Roerig GEOPEN carbenicillin disodium INJECTABLE;INJECTION 050306-007 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-003 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Glaxosmithkline PYOPEN carbenicillin disodium INJECTABLE;INJECTION 050298-007 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Roerig GEOPEN carbenicillin disodium INJECTABLE;INJECTION 050306-002 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
McKesson
Merck
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.